New clinical trial for treatment of COVID-19 positive patients to start at Vancouver Infectious Diseases Centre in partnership with Montreal Heart Institute

Home > Press room > New clinical trial for treatment of COVID-19 positive patients to start at Vancouver Infectious Diseases Centre in partnership with Montreal Heart Institute

April 7, 2020

The Montreal Heart Institute Research Center today announced a strategic partnership with the Vancouver Infectious Diseases Centre (VIDC) in Vancouver, British Colombia, for its COVID-19 clinical study to evaluate whether colchicine will have an effect on preventing the phenomenon of major inflammatory storm present in adults suffering from severe complications related to COVID-19.

find out more by visiting the Institute’s website

 

Physicians with patients, or people with a positive COVID-19 diagnosis who are interested in participating in the clinical study, can call the hotline any time at 1-877-536-6837.

Get all the latest news!

By signing up for our newsletter, you’ll be getting the latest news about the Foundation delivered directly to your inbox.

This field is required
This field is required
This field is requiredAdresse courriel invalide

By submitting your information, you consent to receiving communications from us. You may unsubscribe from our communications at any time.
Please leave this
field empty